A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

The Nigerian Government has reached a landmark agreement for reduction in price of twice-yearly HIV prevention injection, ...

The Federal Government, through the National Agency for the Control of AIDS (NACA), has joined global leaders to endorse a ...

Over 100 low-income countries are expected to have access to a new HIV prevention drug within two years, potentially bringing ...

TWN calls for generic lenacapavir to be made available to all at $40 a year: Our Bureau, New Delhi Friday, September 26, 2025, 08:00 Hrs [IST] Third World Network (TWN), an indepe ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a year and has demonstrated over 99.9% effectiveness in preventing HIV ...

The Federal Government of Nigeria, through the National Agency for the Control of AIDS (NACA), has announced a major ...

Globally, 630,000 people died from HIV-related causes in 2024, while 1.3 million people acquired HIV, including 120,000 ...

Real-time index price for TSX Global Gold EW Index (TXGE), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Nigeria has secured a landmark agreement to drastically cut the cost of a revolutionary HIV prevention drug, lenacapavir, paving the way for millions of citizens to access the life-saving medicine and ...